Amani Therapeutics, Inc. raised $35.0M in its first filing
Amani Therapeutics, Inc. raised $35.0M in a sale that began on September 16, 2026. This is the first SEC Form D filing for the company, which incorporated in 2025. The filing estimates this is a Series B round.
The New York based company operates in the health care sector. The latest filing names Alice Lee and Robert Swoboda as executive officers. Directors include Lauren Cuje, Peter Fong, and Connor Williams. RTW Holdings VI, LLC is listed as a promoter.
We do not track open roles for Amani Therapeutics, Inc. yet.
Every Form D filing
| First sale | Amount sold | Est. round |
|---|---|---|
| 2026-09-16 | $35.0M | Series B |
Named in the latest filing
- Alice Lee
- -- RTW Holdings VI, LLC
- Robert Swoboda
- Lauren Cuje
- Peter Fong
- Connor Williams
From SEC Form D filings. Rounds are our estimate from the amount sold; filings carry no valuation. All filings on SEC EDGAR